ESIC Sets New Standard: Introducing Enhanced Service Level Benchmarks for Healthcare Excellence
The Employees State Insurance Corporation, in a pursuit to elevate the standards of healthcare, announced the implementation of new Service Level Benchmarks designed to significantly enhance the quality of care in our hospitals and dispensaries.
Vaccine Samples Declared Not of Standard Quality 2017-2023
The Central Drugs Standard Control Organization (CDSCO) has released a report detailing various instances of substandard vaccines identified in India over the past six years, i.e. from 2017-2023. The report identified substandard vaccines across various categories, including typhoid, tetanus, polio, and COVID-19 vaccines.
Revised Minimum Wages in Maharashtra: Essential Information for Hospital Workers and Employers
The new minimum wage rates are categorized into three zones based on the geographic and economic conditions of different areas in Maharashtra.
CDSCO Seeks Public Input on Revised Good Clinical Practices Guidelines
Good Clinical Practice is a set of guidelines for biomedical studies which encompasses the design, conduct, termination, audit, analysis, reporting and documentation of the studies involving human participants. Stakeholders are encouraged to submit their comments and suggestions on the draft guidelines. Comments can be submitted electronically within by October 12, 2024 to dci@nic.in.
NPPA Extends Ceiling Prices for Orthopaedic Knee Implants
The NPPA has decided to continue the current ceiling prices for primary and secondary knee replacement systems. The specific ceiling prices for primary and secondary knee replacement systems will remain unchanged for another year, i.e. from September 16, 2024 to September 15, 2025, or until the next revision.
NPPA Fixes Retail Prices For 62 Formulations
The order specifies the retail prices for a total of 62 new drugs for specified strengths and manufacturers. These prices are exclusive of Goods and Services Tax, if applicable. Manufacturers are required to submit a price list in Form–V via IPDMS to the National Pharmaceutical Pricing Authority (NPPA) and provide copies to State Drug Controllers and dealers.
NPPA Revises Ceiling Prices for Chloroquine
NPPA has further increased the ceiling price of 1 Tablet of Chloroquine 150 mg from Rs. 1.17 to Rs. 1.33. The new prices take into account a minimal increase based on the Wholesale Price Index (WPI).
NBEMS Announces DNB Seats Under Joint Accreditation Program
The Joint Accreditation Program is a flagship initiative of NBEMS, designed to ensure quality education and training for medical professionals. NBEMS has allocated a specific number of DNB/Diploma seats to accredited hospitals for the 2024 admission session.
NBEMS Revises Its Stipend Guidelines for Trainee Doctors
Hospitals and institutions are required to adjust stipend rates periodically to reflect revisions made by State or Central Governments for their respective trainee programs. Hospitals cannot reduce the stipend amount in exchange for providing housing.
India Unveils Shorter, More Effective Treatment for Drug-Resistant Tuberculosis
The BPaLM regimen, a four-drug combination, offers a dramatic improvement over traditional MDR-TB treatments. While older methods can last up to 20 months with harsh side effects, the BPaLM regimen can cure drug-resistant TB in just six months with a high success rate.
